David A. Pierce's most recent trade in Diversified Healthcare Trust was a trade of 20,000 Common Shares of Beneficial Interest done . Disclosure was reported to the exchange on June 5, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Diversified Healthcare Trust | David A. Pierce | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2023 | 20,000 | 40,000 (0%) | 0% | - | Common Shares of Beneficial Interest | |
| Boston Scientific | David A. Pierce | EVP Pres MedSurg | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2022 | 2,444 | 0 | - | - | Deferred Stock Units | |
| Boston Scientific | David A. Pierce | EVP Pres MedSurg | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2022 | 2,444 | 2,444 (0%) | 0% | 0 | Common Stock | |
| Boston Scientific | David A. Pierce | EVP Pres MedSurg | Sale of securities on an exchange or to another person at price $ 43.94 per share. | 28 Feb 2022 | 1,726 | 0 (0%) | 0% | 43.9 | 75,840 | Common Stock |
| Boston Scientific | David A. Pierce | EVP Pres MedSurg | Payment of exercise price or tax liability using portion of securities received from the company at price $ 44.17 per share. | 28 Feb 2022 | 718 | 1,726 (0%) | 0% | 44.2 | 31,714 | Common Stock |
| Boston Scientific | David A. Pierce | EVP Pres MedSurg | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2022 | 17,439 | 17,439 | - | - | Performance Share Units | |
| Boston Scientific | David A. Pierce | EVP Pres MedSurg | Sale of securities on an exchange or to another person at price $ 42.55 per share. | 22 Feb 2022 | 1,884 | 1,761 (0%) | 0% | 42.5 | 80,164 | Common Stock |
| Boston Scientific | David A. Pierce | EVP Pres MedSurg | Sale of securities on an exchange or to another person at price $ 43.28 per share. | 22 Feb 2022 | 1,761 | 0 (0%) | 0% | 43.3 | 76,216 | Common Stock |
| Boston Scientific | David A. Pierce | EVP Pres MedSurg | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Feb 2022 | 2,493 | 4,377 (0%) | 0% | 0 | Common Stock | |
| Boston Scientific | David A. Pierce | EVP Pres MedSurg | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Feb 2022 | 2,493 | 2,493 | - | - | Deferred Stock Units | |
| Boston Scientific | David A. Pierce | EVP Pres MedSurg | Payment of exercise price or tax liability using portion of securities received from the company at price $ 42.55 per share. | 21 Feb 2022 | 732 | 3,645 (0%) | 0% | 42.6 | 31,147 | Common Stock |
| Boston Scientific | David A. Pierce | EVP Pres MedSurg | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Feb 2022 | 3,333 | 3,333 (0%) | 0% | 0 | Common Stock | |
| Boston Scientific | David A. Pierce | EVP Pres MedSurg | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Feb 2022 | 3,333 | 10,000 | - | - | Restricted Stock Units | |
| Boston Scientific | David A. Pierce | EVP Pres MedSurg | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Feb 2022 | 2,668 | 5,337 | - | - | Deferred Stock Units | |
| Boston Scientific | David A. Pierce | EVP Pres MedSurg | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Feb 2022 | 2,668 | 5,022 (0%) | 0% | 0 | Common Stock | |
| Boston Scientific | David A. Pierce | EVP Pres MedSurg | Sale of securities on an exchange or to another person at price $ 42.88 per share. | 17 Feb 2022 | 2,354 | 1,884 (0%) | 0% | 42.9 | 100,940 | Common Stock |
| Boston Scientific | David A. Pierce | EVP Pres MedSurg | Payment of exercise price or tax liability using portion of securities received from the company at price $ 42.83 per share. | 17 Feb 2022 | 979 | 2,354 (0%) | 0% | 42.8 | 41,931 | Common Stock |
| Boston Scientific | David A. Pierce | EVP Pres MedSurg | Payment of exercise price or tax liability using portion of securities received from the company at price $ 42.55 per share. | 17 Feb 2022 | 784 | 4,238 (0%) | 0% | 42.5 | 33,359 | Common Stock |
| Boston Scientific | David A. Pierce | EVP Pres MedSurg | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2022 | 2,769 | 2,769 | - | - | Deferred Stock Units | |
| Boston Scientific | David A. Pierce | EVP Pres MedSurg | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2022 | 2,769 | 2,769 (0%) | 0% | 0 | Common Stock | |
| Boston Scientific | David A. Pierce | EVP Pres MedSurg | Sale of securities on an exchange or to another person at price $ 43.81 per share. | 15 Feb 2022 | 1,956 | 0 (0%) | 0% | 43.8 | 85,692 | Common Stock |
| Boston Scientific | David A. Pierce | EVP Pres MedSurg | Payment of exercise price or tax liability using portion of securities received from the company at price $ 44.01 per share. | 15 Feb 2022 | 813 | 1,956 (0%) | 0% | 44.0 | 35,780 | Common Stock |
| Boston Scientific | David A. Pierce | EVP Pres MedSurg | Sale of securities on an exchange or to another person at price $ 43.54 per share. | 04 Jan 2022 | 6,161 | 0 (0%) | 0% | 43.5 | 268,230 | Common Stock |
| Boston Scientific | David A. Pierce | EVP Pres MedSurg | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2022 | 8,982 | 0 | - | - | Performance Share Units | |
| Boston Scientific | David A. Pierce | EVP Pres MedSurg | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2022 | 8,982 | 8,982 (0%) | 0% | 0 | Common Stock | |
| Boston Scientific | David A. Pierce | EVP Pres MedSurg | Payment of exercise price or tax liability using portion of securities received from the company at price $ 42.48 per share. | 01 Jan 2022 | 2,821 | 6,161 (0%) | 0% | 42.5 | 119,836 | Common Stock |
| Boston Scientific | David A. Pierce | EVP Pres MedSurg | Sale of securities on an exchange or to another person at price $ 39.90 per share. | 20 Dec 2021 | 49,988 | 0 (0%) | 0% | 39.9 | 1,994,621 | Common Stock |
| Boston Scientific | David A. Pierce | EVP Pres MedSurg | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.39 per share. | 20 Dec 2021 | 42,934 | 44,991 (0%) | 0% | 7.4 | 317,282 | Common Stock |
| Boston Scientific | David A. Pierce | EVP Pres MedSurg | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Dec 2021 | 42,934 | 0 | - | - | Stock Option (Right to Buy) | |
| Boston Scientific | David A. Pierce | EVP Pres MedSurg | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Dec 2021 | 4,997 | 0 | - | - | Stock Option (Right to Buy) | |
| Boston Scientific | David A. Pierce | EVP Pres MedSurg | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.28 per share. | 20 Dec 2021 | 4,997 | 49,988 (0%) | 0% | 6.3 | 31,381 | Common Stock |
| Boston Scientific | David A. Pierce | EVP Pres MedSurg | Sale of securities on an exchange or to another person at price $ 41.36 per share. | 03 Jun 2021 | 1,654 | 2,057 (0%) | 0% | 41.4 | 68,409 | Common Stock |
| Boston Scientific | David A. Pierce | EVP Pres MedSurg | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2021 | 2,973 | 0 | - | - | Deferred Stock Units | |
| Boston Scientific | David A. Pierce | EVP Pres MedSurg | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2021 | 2,973 | 5,030 (0%) | 0% | 0 | Common Stock | |
| Boston Scientific | David A. Pierce | EVP Pres MedSurg | Payment of exercise price or tax liability using portion of securities received from the company at price $ 42.93 per share. | 01 Jun 2021 | 1,319 | 3,711 (0%) | 0% | 42.9 | 56,625 | Common Stock |
| Boston Scientific | David A. Pierce | EVP Pres MedSurg | Sale of securities on an exchange or to another person at price $ 39.36 per share. | 16 Mar 2021 | 7,603 | 2,057 (0%) | 0% | 39.4 | 299,246 | Common Stock |